CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
166-180 of 959
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
MinuteCE®Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Routes Reconsidered: A Case-Based Debate in SERD Selection
MinuteCE®Routes Reconsidered: A Case-Based Debate in SERD Selection
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®Spotlight on Asia-Pacific: Practice Beyond Borders
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
CME/CEFuture-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
- advertisement
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
CME/CERSV in Infants and Young Children: Are You Taking It Seriously Enough?
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
CME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CEEngaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
- advertisement
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer



































































